HomeCompareQLI vs CL

QLI vs CL: Dividend Comparison 2026

QLI yields 36.97% · CL yields 2.43%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 QLI wins by $7797498278.77M in total portfolio value
10 years
QLI
QLI
● Live price
36.97%
Share price
$5.41
Annual div
$2.00
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$7797498278.82M
Annual income
$7,757,188,590,538,824.00
Full QLI calculator →
CL
CL
● Live price
2.43%
Share price
$85.73
Annual div
$2.08
5Y div CAGR
28.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.8K
Annual income
$5,401.96
Full CL calculator →

Portfolio growth — QLI vs CL

📍 QLI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodQLICL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, QLI + CL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
QLI pays
CL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

QLI
Annual income on $10K today (after 15% tax)
$3,142.33/yr
After 10yr DRIP, annual income (after tax)
$6,593,610,301,958,000.00/yr
CL
Annual income on $10K today (after 15% tax)
$206.23/yr
After 10yr DRIP, annual income (after tax)
$4,591.67/yr
At 15% tax rate, QLI beats the other by $6,593,610,301,953,408.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of QLI + CL for your $10,000?

QLI: 50%CL: 50%
100% CL50/50100% QLI
Portfolio after 10yr
$3898749139.43M
Annual income
$3,878,594,295,272,113.00/yr
Blended yield
99.48%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CL right now

QLI
No analyst data
Altman Z
6.4
Piotroski
3/9
CL
Analyst Ratings
17
Buy
24
Hold
2
Sell
Consensus: Hold
Price Target
$92.45
+7.8% upside vs current
Range: $85.00 — $100.00
Altman Z
4.5
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

QLI buys
0
CL buys
0
No recent congressional trades found for QLI or CL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricQLICL
Forward yield36.97%2.43%
Annual dividend / share$2.00$2.08
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%28.6%
Portfolio after 10y$7797498278.82M$40.8K
Annual income after 10y$7,757,188,590,538,824.00$5,401.96
Total dividends collected$7794837080.52M$18.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: QLI vs CL ($10,000, DRIP)

YearQLI PortfolioQLI Income/yrCL PortfolioCL Income/yrGap
1← crossover$18,094$7,393.72$11,012$312.01+$7.1KQLI
2$44,366$25,005.57$12,196$412.95+$32.2KQLI
3$162,077$114,605.09$13,599$549.66+$148.5KQLI
4$955,989$782,566.99$15,288$736.64+$940.7KQLI
5$9,650,716$8,627,807.42$17,353$995.28+$9.63MQLI
6$173,125,864$162,799,598.80$19,926$1,357.80+$173.11MQLI
7$5,644,105,084$5,458,860,409.25$23,194$1,873.82+$5644.08MQLI
8$338,684,455,283$332,645,262,843.05$27,439$2,621.52+$338684.43MQLI
9$37,672,605,865,602$37,310,213,498,449.27$33,088$3,727.38+$37672605.83MQLI
10$7,797,498,278,815,018$7,757,188,590,538,824.00$40,806$5,401.96+$7797498278.77MQLI

QLI vs CL: Complete Analysis 2026

QLIStock

Qilian International Holding Group Limited engages in the research, development, and production of active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company offers licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions. It also provides Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline APIs for pharmaceutical companies to manufacture medications. In addition, the company offers TCMD products, such as Ahan antibacterial paste to treat refractory chronic skin diseases; heparin products, including heparin sodium preparations for pharmaceutical companies to produce medications for cardiovascular diseases, cerebrovascular diseases, and hemodialysis; and Zhu Xiaochang sausage casings, which are natural food products for culinary application. Further, it provides Xiongguan organic fertilizers to improve crop yield and soil's chemical properties and reduce soil compaction; and Xiongguan organic-inorganic compound fertilizers to increased plant growth. The company was incorporated in 2019 and is based in Jiuquan, the People's Republic of China.

Full QLI Calculator →

CLConsumer Staples

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Full CL Calculator →
📬

Get this QLI vs CL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

QLI vs SCHDQLI vs JEPIQLI vs OQLI vs KOQLI vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.